mGluR5: a potential target for the treatment of Huntington's disease

被引：0
|
作者：
Ribeiro, Fabiola M. [1 ]
Doria, Juliana G. [1 ]
Ferguson, Stephen S. G. [2 ]
机构：
[1] Univ Fed Minas Gerais, ICB, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil
[2] Univ Western Ontario, J Allyn Taylor Ctr Cell Biol, London, ON, Canada
来源：
FUTURE NEUROLOGY | 2014年 / 9卷 / 03期
基金：
加拿大健康研究院;
关键词：
cell signaling; glutamate; Huntington's disease; mGluR5; neurodegeneration;
D O I：
10.2217/FNL.14.14
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：289 / 293
页数：5
相关论文
共 50 条
  • [1] mGluR5 as a Fragile X Treatment Target
    Tranfaglia, Michael R.
    CURRENT NEUROPHARMACOLOGY, 2014, 12 : 59 - 59
  • [2] Therapeutic potential of mGluR5 targeting in Alzheimer's disease
    Kumar, Anil
    Dhull, Dinesh K.
    Mishra, Pooja S.
    FRONTIERS IN NEUROSCIENCE, 2015, 9
  • [3] Development of a glutamate mGluR5 receptor imaging agent in Parkinson and Huntington's disease
    Jennings, D.
    Seibyl, J.
    Barret, O.
    Tamagnan, G.
    Batis, J.
    Alagille, D.
    Lee, S.
    Zubal, G.
    Russell, D.
    Marek, K.
    MOVEMENT DISORDERS, 2011, 26 : S245 - S245
  • [4] PET imaging of mGluR5 in Alzheimer's disease
    Mecca, Adam P.
    McDonald, Julia W.
    Michalak, Hannah R.
    Godek, Tyler A.
    Harris, Joanna E.
    Pugh, Erika A.
    Kemp, Emily C.
    Chen, Ming-Kai
    Salardini, Arash
    Nabulsi, Nabeel B.
    Lim, Keunpoong
    Huang, Yiyun
    Carson, Richard E.
    Strittmatter, Stephen M.
    van Dyck, Christopher H.
    ALZHEIMERS RESEARCH & THERAPY, 2020, 12 (01)
  • [5] PET imaging of mGluR5 in Alzheimer’s disease
    Adam P. Mecca
    Julia W. McDonald
    Hannah R. Michalak
    Tyler A. Godek
    Joanna E. Harris
    Erika A. Pugh
    Emily C. Kemp
    Ming-Kai Chen
    Arash Salardini
    Nabeel B. Nabulsi
    Keunpoong Lim
    Yiyun Huang
    Richard E. Carson
    Stephen M. Strittmatter
    Christopher H. van Dyck
    Alzheimer's Research & Therapy, 12
  • [6] mGluR5 as a Target for the Treatment of L-DOPA-Induced Dyskinesia
    Cenci, M. Angela
    CURRENT NEUROPHARMACOLOGY, 2011, 9 : 9 - 9
  • [7] mGluR5 regulates REST/NRSF signaling through N-cadherin/β-catenin complex in Huntington’s disease
    Jéssica M. de Souza
    Khaled S. Abd-Elrahman
    Fabiola M. Ribeiro
    Stephen S. G. Ferguson
    Molecular Brain, 13
  • [8] Progress on allosteric modulation of mGluR5 and mGluR4: Towards new treatment paradigms in Parkinson's disease
    Celanire, Sylvain
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [9] The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington's disease
    Doria, J. G.
    de Souza, J. M.
    Andrade, J. N.
    Rodrigues, H. A.
    Guimaraes, I. M.
    Carvalho, T. G.
    Guatimosim, C.
    Dobransky, T.
    Ribeiro, F. M.
    NEUROBIOLOGY OF DISEASE, 2015, 73 : 163 - 173
  • [10] mGluR5 regulates REST/NRSF signaling through N-cadherin/β-catenin complex in Huntington's disease
    de Souza, Jessica M.
    Abd-Elrahman, Khaled S.
    Ribeiro, Fabiola M.
    Ferguson, Stephen S. G.
    MOLECULAR BRAIN, 2020, 13 (01)
12345